INSERM (Institut National de la Sante et de la Recherche Medicale);Universite Pierre et Marie Curie (Paris 6);Assistance Publique - Hopitaux de Paris
发明人:
KLATZMANN, David,SAADOUN, David,CACOUB, Patrice,ROSENZWAJG, Michele,PIAGGIO, Eliane,BENSIMON, Gilbert,BERNARD, Claude
申请号：
AU2016273847
公开号：
AU2016273847A2
申请日:
2016.12.13
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2016273847A220170202.pdf#####H: aar lnterwoven NRPortbl DCC AAR 123384451.docx-12/12/2016 ABSTRACT The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
